Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder
- PMID: 17884017
- DOI: 10.1016/j.biopsych.2007.07.009
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder
Abstract
Background: Serotonergic dysfunction has been associated with affective disorders. High trait neuroticism, as measured on personality inventories, is a risk factor for major depression. In this study we investigated whether neuroticism is associated with serotonin 2A receptor binding in brain regions of relevance for affective disorders.
Methods: Eighty-three healthy volunteers completed the standardized personality questionnaire NEO-PI-R (Revised NEO Personality Inventory) and underwent [(18)F]altanserin positron emission tomography imaging for assessment of serotonin 2A receptor binding. The correlation between the neuroticism score and frontolimbic serotonin 2A receptor binding was evaluated by multiple linear regression analysis with adjustment for age and gender.
Results: Neuroticism correlated positively with frontolimbic serotonin 2A receptor binding [r(79) = .24, p = .028]. Post hoc analysis of the contributions from the six constituent traits of neuroticism showed that the correlation was primarily driven by two of them: vulnerability and anxiety. Indeed, vulnerability, defined as a person's difficulties in coping with stress, displayed the strongest positive correlation, which remained significant after correction for multiple comparisons (r = .35, p = .009).
Conclusions: In healthy subjects the personality dimension neuroticism and particularly its constituent trait, vulnerability, are positively associated with frontolimbic serotonin 2A binding. Our findings point to a neurobiological link between personality risk factors for affective disorder and the serotonergic transmitter system and identify the serotonin 2A receptor as a biomarker for vulnerability to affective disorder.
Similar articles
-
Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.Neuropsychopharmacology. 2010 Apr;35(5):1129-37. doi: 10.1038/npp.2009.218. Epub 2009 Dec 30. Neuropsychopharmacology. 2010. PMID: 20043006 Free PMC article.
-
Relationship between neuroticism personality trait and serotonin transporter binding.Biol Psychiatry. 2007 Sep 15;62(6):588-92. doi: 10.1016/j.biopsych.2006.11.007. Epub 2007 Mar 6. Biol Psychiatry. 2007. PMID: 17336939
-
Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.Br J Psychiatry. 2025 Mar;226(3):137-143. doi: 10.1192/bjp.2024.143. Epub 2024 Dec 5. Br J Psychiatry. 2025. PMID: 39632615
-
[Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].Encephale. 2002 Jul-Aug;28(4):363-73. Encephale. 2002. PMID: 12232546 Review. French.
-
Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans.Ann N Y Acad Sci. 2006 Nov;1086:134-43. doi: 10.1196/annals.1377.004. Ann N Y Acad Sci. 2006. PMID: 17185512 Review.
Cited by
-
Emotional stability is associated with the MAOA promoter uVNTR polymorphism in women.Brain Behav. 2019 Sep;9(9):e01376. doi: 10.1002/brb3.1376. Epub 2019 Aug 25. Brain Behav. 2019. PMID: 31448578 Free PMC article.
-
Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.Curr Top Behav Neurosci. 2022;56:187-211. doi: 10.1007/7854_2021_284. Curr Top Behav Neurosci. 2022. PMID: 34910289
-
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.Front Psychol. 2018 Oct 12;9:1721. doi: 10.3389/fpsyg.2018.01721. eCollection 2018. Front Psychol. 2018. PMID: 30369890 Free PMC article.
-
Prediction of psilocybin response in healthy volunteers.PLoS One. 2012;7(2):e30800. doi: 10.1371/journal.pone.0030800. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363492 Free PMC article. Clinical Trial.
-
Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Front Neuroergon. 2022 Jan 20;2:784576. doi: 10.3389/fnrgo.2021.784576. eCollection 2021. Front Neuroergon. 2022. PMID: 38235248 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous